☰

Heather L. Lehman, Ph.D. - Publications

Affiliations: 
2011 Department of Biological Sciences University of Delaware, Newark, DE, United States 
Area:
Cell Biology, Oncology, Molecular Biology
Tree Info Similar researchers PubMed Report error

13 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Lehman HL, Kidacki M, Stairs DB. Twist2 is NFkB-responsive when p120-catenin is inactivated and EGFR is overexpressed in esophageal keratinocytes. Scientific Reports. 10: 18829. PMID 33139779 DOI: 10.1038/s41598-020-75866-0  0.351
2018 Lehman HL, Kidacki M, Warrick JI, Stairs DB. NFkB hyperactivation causes invasion of esophageal squamous cell carcinoma with EGFR overexpression and p120-catenin down-regulation. Oncotarget. 9: 11180-11196. PMID 29541406 DOI: 10.18632/Oncotarget.24358  0.457
2017 Kidacki M, Lehman HL, Green MV, Warrick JI, Stairs DB. p120-Catenin Downregulation and PIK3CA Mutations Cooperate to Induce Invasion through MMP1 in HNSCC. Molecular Cancer Research : McR. PMID 28637905 DOI: 10.1158/1541-7786.Mcr-17-0108  0.37
2017 Joglekar M, Elbazanti WO, Weitzman MD, Lehman HL, van Golen KL. Caveolin-1 Mediates Inflammatory Breast Cancer Cell Invasion via the Akt1 Pathway and RhoC GTPase. Journal of Cellular Biochemistry. 118: 1273. PMID 28316145 DOI: 10.1002/Jcb.25876  0.769
2016 Karagoz K, Lehman HL, Stairs DB, Sinha R, Arga KY. Proteomic and Metabolic Signatures of Esophageal Squamous Cell Carcinoma. Current Cancer Drug Targets. PMID 26845434 DOI: 10.2174/1568009616666160203113721  0.354
2016 Lehman HL, Welsh PA, Kidacki M, Warrick JI, Stairs DB. Tu1175 NFkB Regulates the Invasive Potential of Esophageal Squamous Cell Carcinoma Downstream of EGFR and p120ctn Gastroenterology. 150: S854-S855. DOI: 10.1016/S0016-5085(16)32885-2  0.366
2015 Joglekar M, Elbazanti WO, Weitzman MD, Lehman HL, van Golen KL. Caveolin-1 mediates inflammatory breast cancer cell invasion via the Akt1 pathway and RhoC GTPase. Journal of Cellular Biochemistry. 116: 923-33. PMID 25559359 DOI: 10.1002/Jcb.25025  0.768
2015 Lehman HL, Yang X, Welsh PA, Stairs DB. p120-catenin down-regulation and epidermal growth factor receptor overexpression results in a transformed epithelium that mimics esophageal squamous cell carcinoma. The American Journal of Pathology. 185: 240-51. PMID 25529795 DOI: 10.1016/J.Ajpath.2014.09.008  0.446
2014 Masse J, Welsh PA, Lehman HL, Stairs DB. 49 Investigating the Mechanisms That Drive Invasion in p120-Catenin Knockout Esophageal Keratinocytes Gastroenterology. 146: S-14. DOI: 10.1016/S0016-5085(14)60049-4  0.32
2013 Lehman HL, Dashner EJ, Lucey M, Vermeulen P, Dirix L, Van Laere S, van Golen KL. Modeling and characterization of inflammatory breast cancer emboli grown in vitro. International Journal of Cancer. 132: 2283-94. PMID 23129218 DOI: 10.1002/Ijc.27928  0.416
2012 Lehman HL, Van Laere SJ, van Golen CM, Vermeulen PB, Dirix LY, van Golen KL. Regulation of inflammatory breast cancer cell invasion through Akt1/PKBα phosphorylation of RhoC GTPase. Molecular Cancer Research : McR. 10: 1306-18. PMID 22896661 DOI: 10.1158/1541-7786.Mcr-12-0173  0.755
2012 Lehman H, Daasner E, Vermeulen P, Dirix L, Laere SV, Golen Kv. Abstract P3-10-08: A new in vitro method of growing and studying inflammatory breast cancer emboli Cancer Research. 72. DOI: 10.1158/0008-5472.Sabcs12-P3-10-08  0.781
2012 Lehman H, Laere SV, Golen Cv, Vermeulen P, Dirix L, Golen Kv. Abstract P3-10-04: Regulation of inflammatory breast cancer cell invasion through Akt1/PKBα phosphorylation of RhoC GTPase Cancer Research. 72. DOI: 10.1158/0008-5472.Sabcs12-P3-10-04  0.73
Show low-probability matches.